Increases in the size, number and proliferation rate of VIP-immunoreactive pituitary cells induced in vitro by TRH are associated with increases in VIP release

European Journal of Anatomy

Volumn 7, Issue 2, 2003, Pages 91-95

  Carretero, Joś ^a,b   Torres, J L ^a   Rubio, M ^a   Burks, D J ^a   Sierra, E ^a   Angoso, M ^a   Blanco, E ^a   Herrero, J ^a   Vazquez R ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Cellular proliferation; Immunohistochemistry; Pituitary gland; TRH; VIP

Indexed keywords

CYCLINE; PROTIRELIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL CELL; ARTICLE; CELL COUNT; CELL DENSITY; CELL PROLIFERATION; CELL SIZE; HORMONAL REGULATION; HORMONE RELEASE; HYPOPHYSIS CELL; HYPOTHYROIDISM; IMMUNOCYTOCHEMISTRY; MALE; NEUROSECRETORY CELL; NONHUMAN; PROTEIN EXPRESSION; RAT;

EID: 0742305586     PISSN: 11364890     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. BRAVO R, FRANK R, BLUNDELL PA and MACDONALD-BRAVO H (1987). Cyclin-PCNA is the auxiliary protein of DNA polymerase delta. Nature, 326: 515-517.
2. BUHL T, GEROG B, NILSSON C, MIKKELSEN JD, WULFF BS and FAHRENKRUG J (1995). Effect of thyroid hormones on vasoactive intestinal polypeptide gene expression in the rat cerebral cortex and anterior pituitary. Regul Pept, 55: 237-251.
3. CARRETERO J, SÁNCHEZ F, RUBIO M, LORENZO MJ, FRANCOS M, CACICEDO L, SÁNCHEZ-FRANCO F and VÁZQUEZ R (1992). Immunocytochemical evidence of hypothalamic regulation of adenohypophyseal VIP in the male rat. Neuropeptides, 23: 239-243.
4. CARRETERO J, SÁNCHEZ F, RUBIO M, FRANCOS CM, BLANCO J and VÁZQUEZ R (1994). In vitro and in vivo evidence for direct dopaminergic inhibition of VIP-immunoreactive pituitary cells. Neuropeptides, 27: 1-6.
5. CARRETERO J, RUBIO M, SÁNCHEZ F, VÁZQUEZ RJ, SANTOS M, BLANCO E and VÁZQUEZ R (1995a). In vitro morphometric and proliferative variations in VIP-immunoreactive pituitary cells induced by estradiol. Neuroendocrinology, 62: 277-282.
6. CARRETERO J, RUBIO M, NAVARRO N, PRIETO P, VÁZQUEZ RJ, SÁNCHEZ F and VÁZQUEZ R (1995b). In vitro modifications in the proiferation rate of prolactin cells are accompanied by nuclear morphometric variations. Histol Histopathol, 10: 135-139.
7. CARRETERO J, VÁZQUEZ RJ, SANTOS M, CACICEDO L, RUBIO M, SÁNCHEZ-FRANCO F and VÁZQUEZ R (1996). Dopamine inhibits in vitro release of VIP and proliferation of VIP-immunoreactive pituitary cells. Neuropeptides, 30: 81-86.
8. CARRETERO J, RUBIO M, VÁZQUEZ-PERFECTO RJ, SÁNCHEZ F, TORRES JL, PÉREZ RM and VÁZQUEZ R (1997). Decreases in the size and proliferation rate of VIP-immunoreactive cells induced in vitro by testosterone are associated with decreases in VIP release. Neuroendocrinology, 65: 173-178.
9. CARRETERO J, VÁZQUEZ RJ, SÁNCHEZ F, RUBIO M, SANTOS M, VÁZQUEZ G, MARTÍN-CLAVIJO A and VÁZQUEZ R (1998). Inverse effects of estradiol and testosterone on the in vitro proliferation rate of rat VIP-immunoreactive pituitary cells. Eur J Anat, 2: 101-108.
10. CARRILLO AJ, DOHERTY PC, GUAN X, STURTEVANT JR and WALRO DJ (1991). Preferential increase of pituitary vasoactive intestinal peptide as a function of estradiol benzoate dose in the ovariectomized rat. Endocrinology, 128: 131-138.
11. CARRILLO AJ and PHELPS CJ (1992). Quantification of vasoactive intestinal peptide immunoreactivity in the anterior pituitary glands of intact male and female, ovariectomized, and estradiol benzoate-treated rats. Endocrinology, 131: 964-969.
12. COLTRERA C and GOWN AM (1991). PCNA/Cyclin expression and BrDU uptake defie different subpopulations in different cell lines. J Histochem Cytochem, 39: 23-30.
13. HALL PA; LEVISON DA, WOODS AL, YU CCW, KELLOCK DB, WATKINS JA, BARNES DM, GILLET CE, CAMPLEJOHN R, DOVER R, WASEEM NH and LANE DP (1990). Proliferating cell nuclear antigen immunolocalization in paraffin sections: An index of cell proliferation with evidence of regulated expression in some neoplasms. J Pathol, 162: 285-294.
14. JONES PM, O'HALLORAN DJO, GATHEI MA, DOMIN J and BLOOM SR (1990). The influence of adrenal hormone status on neuroendocrine peptides in the rat anterior pituitary gland. J Endocrinol, 127: 437-444.
15. JONES PM, GHATEI MA, WALLIS SC and BLOOM SR (1994). Differential response of neuropeptide Y, susbtsance P and vasoactive intestinal polypeptide in the rat anterior pituitary gland to alterations in thyroid hormone status. J Endocrinol, 143: 393-397.
16. KASPER S, POPESCU RA, TORSELLO A, VRONTAKIS ME, IKEJIANI C and FRIESEN HG (1992). Tissue-specific regulation of vasoactive intestinal peptide messenger ribonucleic acid levels by estrogen in the rat. Endocrinology, 130: 1796-1801.
17. KÖVES K, GOTTSCHALL PE, GORCS T, SCAMMELL JG and ARIMURA A (1990). Presence of immunoreactive vasoactive intestinal polypeptide in anterior pituitary of normal male and long term estrogen-treated female rats: a light microscopic immunohistochemical study. Endocrinology, 126: 1756-1763.
18. LAM KSL (1991). Vasoactive intestinal peptide in the hypothalamus and pituitary. Neuroendocrinology, 53 (suppl 1): 45-51.
19. LAM KSL and REICHLIN S (1989). Pituitary vasoactive intestinal peptide stimulates prolactin secretion in the hypothyroid rat. Neuroendocrinology, 50: 524-528.
20. LAM KSL, LECHAN RM, MINAMITANI N, SEGERSON TP and REICHLIN S (1989). Vasoactive intestinal peptide in the anterior pituitary is increased in hypothyroidism. Endocrinology, 124: 1077-1084.
21. LAM KSL, SRIVASTAVA G, LECHAN RM, LEE T and REICHLIN S (1990). Estrogen regulates the gene expression of vasoactive intestinal peptide in the anterior pituitary. Neuroendocrinology, 52: 417-421.
22. LAM KSL, SRIVASTAVA G and TAM SP (1992). Divergent effects of glucocorticoid on the gene expression of vasoactive intestinal peptide in the rat cerebral cortex and pituitary. Neuroendocrinology, 56: 32-37.
23. LASAGA M, DUVILANSKY BH, SEILICOVICH A, AFIONE S, DÍAZ MC, PISERA D, TRAKTENBERG R and DEBELJUK L (1991). The effect of gonadal steroids in vasoactive intestinal peptide concentration and release from mediobasal hypothalamus and the anterior pituitary gland. J Neuroendocrinol, 3: 75-78.
24. LORENZO MJ, SÁNCHEZ-FRANCO F, DE LOS FRAILES MT, REICHLIN S, FERNÁNDEZ G and CACICEDO L (1989). Synthesis and secretion of vasoactive intestinal peptide by rat fetal cerebral cortical and hypothalamic cells in culture. Endocrinology, 125: 1983-1990.
25. MATHEWS MB, BERNSTEIN RM, FRANZA BR and GARRELS JI (1984). Identity of the proliferating cell nuclear antigen and cyclin. Nature, 303: 374-376.
26. MICHALKIEWICZ M and SUZUKI M (1994). Adenohypophyseal vasoactive intestinal peptide and neuropeptide Y responses to hypothyroidism are abolished after anterolateral deafferentation of the hypothalamus. Neuroendocrinology, 59: 85-91.
27. MOREL G, BESSON J, ROSSELIN G and DUBOIS PM (1982). Ultrastructural evidence for endogenous vasoactive intestinal peptide-like immunoreactivity in the pituitary gland. Neuroendocrinology, 34: 85-89.
28. NAGY G, MULCHAHEY JJ and NEILL JD (1988). Autocrine control of prolactin secretion by vasoactive intestinal peptide. Endrocrinology, 122: 364-366.
29. O'HALLORAN DJ, JONES PH, GHATEI MA, DOMIN J and BLOOM SR (1990). The regulation of neuropeptide expression in rat anterior pituitary following chronic manipulation of estrogen status: a comparison between substance P, neuropeptide Y, neurotensin and vasoactive intestinal peptide. Endocrinology, 127: 1463-1469.
30. OISHI Y, OKUDA M, TAKAHASHI H, FUJII T and MORII S (1993). Cellular proliferation in the anterior pituitary gland of normal adult rats: Influences of sex, estrous cycle, and circadian change. Anat Rec, 235: 111-120.
31. PRELICH G and STILLMAN B (1988). Coordinated leading and lagging strand synthesis during SV40 DNA replication in vitro requires PCNA. Cell, 53: 117-126.
32. PRYSOR-JONES RA, SILVERMAN JJ, KENNEDY SJ and JENKINS JS (1988). Vasoactive intestinal peptide and the stimulation of lactotroph growth by oestradiol in rats. J Endocrinol, 166: 259-265.
33. SARKAR DK (1989). Evidence for prolactin feedback actions on hypothalamic oxytocin, vasoactive intestinal peptide and dopamine secretion. Neuroendocrinology, 49: 520-524.
34. SEGERSON TP, LAM KSL, CACICEDO L, MINAMITANI N, FINK JS, LECHAN RM and REICHLIN S (1989). Thyroid hormone regulates vasoactive intestinal peptide (VIP) mRNA levels in the rat anterior pituitary gland. Endocrinology, 125: 2221-2223.
35. TAN CK, CASTILLO C, SO AG and DOWNEY KM (1986). An auxiliary protein for DNA polymerase delta from fetal calf thymus. J Biol Chem, 261: 1231-1236.
36. WATANOBE H and TAKEBE K (1992). A comparative study of the effects of neonatal androgenization and estrogenization of vasoactive intestinal peptide levels in the anterior pituitary and the hypothalamus of adult female rats. Neuroendocrinology, 56: 653-659.
37. WEIBEL ER (1969). Stereological principles for morphometry in electron microscopic cytology. Int Rev Cytol, 26: 235-302.